USE OF ODC INHIBITORS,DACARBAZINE,AND INTERFERON IN THE TREATMENT OF MALIGNANT MELANOMA

摘要

This invention relates to the improvement of the polyamine depletion effects of ornithine decarboxylase inhibitors, the improvement being effected by the use of Interferon and Dacarbazine in conjunctive therapy with said inhibitors.